Cognitive Biases Under Ketamine

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 8, 2014

Primary Completion Date

April 28, 2022

Study Completion Date

April 29, 2022

Conditions
Healthy Subjects
Interventions
DRUG

Ketamine

"KETAMINE PANPHARMA 250 mg/5mL, solution for infusion :~* Initial rapid infusion of 0,23 mg/kg~* Infusion from minute 2 to minute 30 : 0,00967 mg/kg/min~* Infusion from minute 31 to minute 120 : 0,00483 mg/kg/min"

DRUG

Placebo

"CHLORURE DE SODIUM 0,9 % MACOPHARMA :~* Initial rapid infusion of 0,23 mg/kg~* Infusion from minute 2 to minute 30 : 0,00967 mg/kg/min~* Infusion from minute 31 to minute 120 : 0,00483 mg/kg/min"

Trial Locations (1)

75014

Centre Hospitalier Sainte Anne, Paris

All Listed Sponsors
collaborator

Fondation pour la Recherche Médicale

OTHER

collaborator

Fondation Fyssen

UNKNOWN

collaborator

Comité pour la Recherche Hospitalière Médicale

UNKNOWN

collaborator

Association Schizo Oui

UNKNOWN

lead

Centre Hospitalier St Anne

OTHER

NCT02235012 - Cognitive Biases Under Ketamine | Biotech Hunter | Biotech Hunter